Corrigendum: Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer

Lin Deng,Haiyan Liang,Yi Han

DOI: https://doi.org/10.3389/fonc.2020.582704

IF: 4.7

2020-11-03

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00056.].

oncology

What problem does this paper attempt to address?

Corrigendum: Bioinformatics Analysis Identififies Molecular Markers Regulating Development and Progression of Endometriosis and Potential Therapeutic Drugs

Ying Peng,Cheng Peng,Zheng Fang,Gang Chen

DOI: https://doi.org/10.3389/fgene.2021.793656

IF: 3.7

2022-01-05

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.622683.].

genetics & heredity
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Hongda Pan,Jingxin Pan,Shibo Song,Lei Ji,Hong Lv,Zhangru Yang

DOI: https://doi.org/10.3389/fonc.2021.670041

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00643.].
Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway

Yue Wang,Ying Li,Liang Wang,Buze Chen,Miaolin Zhu,Chunyi Ma,Chunyan Mu,Aibin Tao,Shibao Li,Lan Luo,Ping Ma,Shuai Ji,Ting Lan

DOI: https://doi.org/10.3389/fphar.2024.1427330

2024-07-08

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.779608.].
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Xiaofan Hu,Mingyang Bao,Jiacheng Huang,Lin Zhou,Shusen Zheng

DOI: https://doi.org/10.3389/fonc.2020.617539

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:CORRECTION article Front. Oncol., 20 November 2020Sec. Molecular and Cellular Oncology Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.617539
Corrigendum: Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer

Peng-Ju Gong,You-Cheng Shao,Si-Rui Huang,Yi-Fan Zeng,Xiao-Ning Yuan,Jing-Jing Xu,Wei-Nan Yin,Lei Wei,Jing-Wei Zhang

DOI: https://doi.org/10.3389/fonc.2020.637481

IF: 4.7

2021-01-29

Frontiers in Oncology

Abstract:[This corrects the article .].

oncology
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Xiaoyu Zhang,Xiaoqin He,Yue Li,Yangtao Xu,Wenliang Chen,Xin Liu,Xinyao Hu,Lin Xiong,Ximing Xu

DOI: https://doi.org/10.3389/fmolb.2021.826905

IF: 6.113

2021-12-22

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.702206.].

biochemistry & molecular biology
Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Fang-Ze Wei,Shi-Wen Mei,Zhi-Jie Wang,Jia-Nan Chen,Hai-Yu Shen,Fu-Qiang Zhao,Juan Li,Zheng Liu,Qian Liu

DOI: https://doi.org/10.3389/fonc.2020.634122

IF: 4.7

2020-12-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.573295.].

oncology
Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Wan He,Gengpeng Lin,Chaohu Pan,Wenwen Li,Jing Shen,Yangli Liu,Hui Li,Dongfang Wu,Xuejia Lin

DOI: https://doi.org/10.3389/fgene.2022.879922

IF: 3.7

2022-03-11

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.761681.].

genetics & heredity
Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Sen Miao,Gaoda Ju,Chonghua Jiang,Bing Xue,Lihua Zhao,Rui Zhang,Han Diao,Xingzhou Yu,Linlin Zhang,Xiaozao Pan,Hua Zhang,Lijuan Zang,Lei Wang,Tianhao Zhou

DOI: https://doi.org/10.3389/fmed.2024.1375203

IF: 3.9

2024-02-05

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1167676.].

medicine, general & internal
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Meng-Xia Zhang,Li Wang,Lei Zeng,Zi-Wei Tu

DOI: https://doi.org/10.3389/fonc.2021.670714

IF: 4.7

2021-03-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.605777.].

oncology
Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Sheng Liu,Wenting Tang,Jing Cao,Mei Shang,Sun Hengchang,Jiao Gong,Bo Hu

DOI: https://doi.org/10.3389/fgene.2024.1357409

IF: 3.7

2024-01-26

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.904114.].

genetics & heredity
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Yaxin Chen,Lei Xia,Yuxuan Peng,Gang Wang,Liyun Bi,Xue Xiao,Cui Li,Weimin Li

DOI: https://doi.org/10.3389/fonc.2023.1309950

IF: 4.7

2023-11-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.947808.].

oncology
Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma

Nguyen Van Hiep,Wei-Lun Sun,Po-Hao Feng,Cheng-Wei Lin,Kuan-Yuan Chen,Ching-Shan Luo,Le Ngoc Dung,Hoang Van Quyet,Sheng-Ming Wu,Kang-Yun Lee

DOI: https://doi.org/10.3389/fonc.2022.1106553

IF: 4.7

2022-12-13

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.963896.].

oncology
Erratum: Synergism from the Combination of Ulinastatin and Curcumin Offers Greater Inhibition against Colorectal Cancer Liver Metastases via Modulating Matrix Metalloproteinase-9 and E-Cadherin Expression [Corrigendum]

DOI: https://doi.org/10.2147/OTT.S493466

2024-09-25

Abstract:[This corrects the article DOI: 10.2147/OTT.S57126.].
Corrigendum to "Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment" [Comput Struct Biotechnol J 20 (2022) 3322-3335]

Wenwen Wang,Jingjing Zhang,Yuqing Wang,Yasi Xu,Shirong Zhang

DOI: https://doi.org/10.1016/j.csbj.2023.10.048

2023-11-01

Abstract:[This corrects the article DOI: 10.1016/j.csbj.2022.06.046.].
High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum

Ming Cui,Lei You,Bang Zheng,Xinmei Huang,Qiaofei Liu,Jing Huang,Boju Pan,Xiaoyan Qiu,Quan Liao,Yupei Zhao

DOI: https://doi.org/10.7150/jca.32930

IF: 3.9

2021-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.39800.].
Corrigendum: Development and validation of a prognostic nomogram based on DNA methylation-driven genes for patients with ovarian cancer

Min Zhou,Shasha Hong,Bingshu Li,Cheng Liu,Ming Hu,Jie Min,Jianming Tang,Li Hong

DOI: https://doi.org/10.3389/fgene.2022.951409

IF: 3.7

2022-08-15

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.675197.].

genetics & heredity

Corrigendum: Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer

Corrigendum: Bioinformatics Analysis Identififies Molecular Markers Regulating Development and Progression of Endometriosis and Potential Therapeutic Drugs

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Corrigendum: Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma

Erratum: Synergism from the Combination of Ulinastatin and Curcumin Offers Greater Inhibition against Colorectal Cancer Liver Metastases via Modulating Matrix Metalloproteinase-9 and E-Cadherin Expression [Corrigendum]

Corrigendum to "Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment" [Comput Struct Biotechnol J 20 (2022) 3322-3335]

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum

Corrigendum: Development and validation of a prognostic nomogram based on DNA methylation-driven genes for patients with ovarian cancer